14 WiSys Technologies in "Pharmaceuticals & Vitamin D" or "Research Tools" or "Food & Supplements" or "Medical Imaging"
Researchers from the University of Wisconsin - Stevens Point are part of a multi-institution research team that has developed a vaccine with proven efficacy in preventing Francisella infections in fish.
WiSys is seeking strategic partners interested in the commercial use of this innovation
WiSys is seeking a strategic partner skilled in the manufacturing and distribution of insulated storage containers or portable mini refrigerators. Ideally, this partner could provide a route to market for the commercialization and use of this retrofit Peltier cooling device.
WiSys is seeking a strategic partner interested in providing a route to market for the commercialization and use of this anthocyanin extraction system. There is also interest in partnering with a fruit processing company for the continued testing and scaling of this system.
WiSys Technology Foundation is seeking a strategic partner with an industry player in the life science tools and reagents industry for the further development and commercialization of its novel monomeric fluorescent protein.
WiSys Technology Foundation is currently seeking a strategic industry partner to assist in the further development of its lead compound, A11, and related analogues providing a route to market for their use as novel skin whitening/lightening agents.The competitive advantage of these compounds over existing agents on the market is that they produce long-acting and reversible skin lightening with no toxicity.
WiSys Technology Foundation is seeking a strategic partner to further develop, manufacture, market, and distribute a high accuracy rotary (angle) encoder. This device has the advantages of high single-reading accuracy (±0.1 arc seconds) and high average reading sensitivity (0.001 arc seconds), low production cost, compact design, and low power consumption. Possible applications include but are not limited to astronomical telescope mounts, land surveillance tools, industrial inspection and calibration, machine tools, medical devices, as well as robotics.
The WiSys Technology Foundation is seeking commercial partners interested in developing anxiolytic and anticonvulsant benzodiazepines that offer little or no side effects.